Biomarkers in Prostate-Specific Membrane Antigen Theranostics

Theranostics of prostate cancer (PC) represents a growing area of development of imaging agents and targeted radionuclide therapeutics against a major target, prostate specific membrane antigen (PSMA). In view of the encouraging efficacy from the use of (177)Lu and other radionuclides in metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlachostergios, Panagiotis J., Zachos, Ioannis, Tzortzis, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235046/
https://www.ncbi.nlm.nih.gov/pubmed/34207069
http://dx.doi.org/10.3390/diagnostics11061108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235046/
https://www.ncbi.nlm.nih.gov/pubmed/34207069
http://dx.doi.org/10.3390/diagnostics11061108

Ejemplares similares